2 weeks Ago By ABMN Staff
Renaissance Technologies LLC increased its stake in shares of Inogen, Inc. ( NASDAQ:INGN – Free Report ) by 17.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 492,900 shares of the medical technology company’s stock after purchasing an additional 75,000 shares during the quarter. Renaissance Technologies LLC owned 2.07% of Inogen worth $4,520,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the stock. Invesco Ltd. increased its stake in shares of Inogen by 2.
0% during the fourth quarter. Invesco Ltd. now owns 78,142 shares of the medical technology company’s stock worth $717,000 after buying an additional 1,545 shares during the period.
Federated Hermes Inc. increased its position in shares of Inogen by 16.8% in the 4th quarter.
Federated Hermes Inc. now owns 404,273 shares of the medical technology company’s stock valued at $3,707,000 after purchasing an additional 58,257 shares during the last quarter. Dynamic Technology Lab Private Ltd raised its holdings in shares of Inogen by 66.
4% in the 4th quarter. Dynamic Technology Lab Private Ltd now owns 33,770 shares of the medical technology company’s stock valued at $310,000 after purchasing an additional 13,474 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Inogen by 27.
8% during the 4th quarter. Wells Fargo & Company MN now owns 13,917 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 3,031 shares during the last quarter. Finally, Integrated Quantitative Investments LLC acquired a new position in shares of Inogen during the fourth quarter worth $92,000.
Hedge funds and other institutional investors own 89.94% of the company’s stock. Inogen Stock Down 1.
2 % Shares of NASDAQ:INGN opened at $6.74 on Tuesday. The company has a market cap of $181.
22 million, a price-to-earnings ratio of -3.00 and a beta of 1.48.
Inogen, Inc. has a fifty-two week low of $6.40 and a fifty-two week high of $13.
33. The firm’s 50-day simple moving average is $7.88 and its 200-day simple moving average is $9.
12. Wall Street Analysts Forecast Growth Read Our Latest Research Report on INGN Inogen Profile ( Free Report ) Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Featured Articles Want to see what other hedge funds are holding INGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inogen, Inc. ( NASDAQ:INGN – Free Report ).
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter ..
